DR. MANDI ELKINS SMITH O.D.
Prescription History 1982918421
Optometrist in Gulfport, MS

Active since July 26, 2010PECOS EnrolledAccepts Medicare Assignment
450 E PASS RD, GULFPORT, MS 39507(228) 896-8916 Get Directions

NPPES record last updated: October 28, 2021. Verified against the NPPES registry weekly; last sync: August 09, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MANDI ELKINS SMITH O.D., an active Optometrist specialist practicing in Gulfport, MS. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 670 documented patient claims. Among these therapy options, the most frequently utilized medication is Lumigan, which accounts for 201 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

8
Medications
670
Total Claims
1,130
30-Day Fills
Lumigan
Most Prescribed · 201 claims
View details
8 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by DR. MANDI ELKINS SMITH O.D. in 2023, with prescription volumes, average cost per fill, and MS state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other MS PrescribersVs. MS Avg

About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2023, this provider wrote 201 Medicare prescriptions for Lumigan, about 3.2 times the volume of the typical Mississippi prescriber of this medication (63). Medicare paid an average of $481.37 per fill, versus $394.75 statewide.

How often this provider prescribes it

This provider
201
MS average
63.0

This provider prescribes this medication more often than the average MS prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$481.37
MS average
$394.75

Gross Part D cost per fill; not the patient's out-of-pocket price.

316.1
30-Day Fills
standardized to 30-day supplies
9,232
Days of Medication
total across all patients in 2023

About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾

It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

In 2023, this provider wrote 188 Medicare prescriptions for Latanoprost, about the same volume as the typical Mississippi prescriber of this medication (179). Medicare paid an average of $15.19 per fill, versus $14.31 statewide.

How often this provider prescribes it

This provider
188
MS average
179.0

This provider's prescribing volume for this medication is in line with the average MS prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$15.19
MS average
$14.31

Gross Part D cost per fill; not the patient's out-of-pocket price.

352.2
30-Day Fills
standardized to 30-day supplies
10,248
Days of Medication
total across all patients in 2023

About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾

Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2023, this provider wrote 85 Medicare prescriptions for Brimonidine Tartrate, about 1.3 times the volume of the typical Mississippi prescriber of this medication (67). Medicare paid an average of $16.28 per fill, versus $32.07 statewide.

How often this provider prescribes it

This provider
85
MS average
67.0

This provider prescribes this medication more often than the average MS prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$16.28
MS average
$32.07

This provider's average cost per fill is below the MS average for this medication.

128
30-Day Fills
standardized to 30-day supplies
3,335
Days of Medication
total across all patients in 2023

About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2023, this provider wrote 53 Medicare prescriptions for Travoprost, about 2 times the volume of the typical Mississippi prescriber of this medication (27). Medicare paid an average of $197.98 per fill, versus $191.46 statewide.

How often this provider prescribes it

This provider
53
MS average
27.0

This provider prescribes this medication more often than the average MS prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$197.98
MS average
$191.46

Gross Part D cost per fill; not the patient's out-of-pocket price.

93.7
30-Day Fills
standardized to 30-day supplies
2,753
Days of Medication
total across all patients in 2023

About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors.

In 2023, this provider wrote 48 Medicare prescriptions for Dorzolamide-Timolol, about half the volume of the typical Mississippi prescriber of this medication (81). Medicare paid an average of $30.62 per fill, versus $30.10 statewide.

How often this provider prescribes it

This provider
48
MS average
81.0

This provider prescribes this medication less often than the average MS prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$30.62
MS average
$30.10

Gross Part D cost per fill; not the patient's out-of-pocket price.

78.4
30-Day Fills
standardized to 30-day supplies
2,341
Days of Medication
total across all patients in 2023

About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.

In 2023, this provider wrote 47 Medicare prescriptions for Combigan, about the same volume as the typical Mississippi prescriber of this medication (46). Medicare paid an average of $400.06 per fill, versus $332.73 statewide.

How often this provider prescribes it

This provider
47
MS average
46.0

This provider's prescribing volume for this medication is in line with the average MS prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$400.06
MS average
$332.73

Gross Part D cost per fill; not the patient's out-of-pocket price.

88.1
30-Day Fills
standardized to 30-day supplies
2,514
Days of Medication
total across all patients in 2023

About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.

In 2023, this provider wrote 26 Medicare prescriptions for Timolol Maleate, about a third of the volume of the typical Mississippi prescriber of this medication (63). Medicare paid an average of $7.61 per fill, versus $17.20 statewide.

How often this provider prescribes it

This provider
26
MS average
63.0

This provider prescribes this medication less often than the average MS prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$7.61
MS average
$17.20

This provider's average cost per fill is below the MS average for this medication.

50
30-Day Fills
standardized to 30-day supplies
1,499
Days of Medication
total across all patients in 2023

About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾

Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2023, this provider wrote 22 Medicare prescriptions for Alphagan P, about 67% of the volume of the typical Mississippi prescriber of this medication (33). Medicare paid an average of $218.01 per fill, versus $331.57 statewide.

How often this provider prescribes it

This provider
22
MS average
33.0

This provider prescribes this medication less often than the average MS prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$218.01
MS average
$331.57

This provider's average cost per fill is below the MS average for this medication.

23.2
30-Day Fills
standardized to 30-day supplies
472
Days of Medication
total across all patients in 2023
No medications match the current filters.
= the 5 medications this provider prescribes most. More than typical Typical Less than typical= prescription volume vs the average MS prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the MS average cost per fill.

About this data. The prescription history for DR. MANDI ELKINS SMITH O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Gulfport, MS practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MS prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.